Cleared Traditional

K070452 - VARIANT II HEMOGLOBIN A1C PROGRAM WITH MODELS 270-2101NU (FDA 510(k) Clearance)

May 2007
Decision
80d
Days
Class 2
Risk

K070452 is an FDA 510(k) clearance for the VARIANT II HEMOGLOBIN A1C PROGRAM WITH MODELS 270-2101NU. This device is classified as a Assay, Glycosylated Hemoglobin (Class II - Special Controls, product code LCP).

Submitted by Bio-Rad Laboratories, Inc. (Hercules, US). The FDA issued a Cleared decision on May 7, 2007, 80 days after receiving the submission on February 16, 2007.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 864.7470.

Submission Details

510(k) Number K070452 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 2007
Decision Date May 07, 2007
Days to Decision 80 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LCP — Assay, Glycosylated Hemoglobin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7470